Scar tissue to lung cancer; pathways and treatment

被引：4

作者：

Sapalidis, Konstantinos ^{[1
]}

Sardeli, Chrysanthi ^{[2
]}

Pavlidis, Efstathios ^{[1
]}

Koimtzis, Georgios ^{[1
]}

Koulouris, Charilaos ^{[1
]}

Michalopoulos, Nikolaos ^{[1
]}

Mantalovas, Stylianos ^{[1
]}

Tsiouda, Theodora ^{[1
]}

Passos, Ioannis ^{[1
]}

Kosmidis, Christoforos ^{[1
]}

Giannakidis, Dimitrios ^{[1
]}

Surlin, Valeriu ^{[1
]}

Katsaounis, Athanasios ^{[1
]}

Alexandrou, Vyron ^{[1
]}

Amaniti, Aikaterini ^{[3
]}

Zarogoulidis, Paul ^{[1
,2
]}

Huang, Haidong ^{[4
]}

Li, Qiang ^{[4
]}

Mogoanta, Stelian ^{[5
]}

Kesisoglou, Isaac ^{[1
]}

机构：

[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Med Sch, Dept Surg 3, Thessaloniki, Greece

[2] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Med, Dept Pharmacol & Clin Pharmacol, Thessaloniki, Greece

[3] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Med Sch, Anaisthisiol Dept, Thessaloniki, Greece

[4] Tongji Univ, Shanghai East Hosp, Diagnost & Therapeut Ctr Resp Dis, Shanghai, Peoples R China

[5] Univ Med & Pharm Craiova, Fac Dent, Dept Surg, Craiova, Romania

来源：

JOURNAL OF CANCER | 2019年 / 10卷 / 04期

关键词：

lung cancer; scar tissue; interstitial disease; fibrosis; pathways; IDIOPATHIC PULMONARY-FIBROSIS; EGFR MUTATION DETECTION; LIQUID BIOPSY; DISEASE; PNEUMONITIS; NSCLC; OSIMERTINIB; MECHANISMS; CRIZOTINIB; RESISTANCE;

D O I：

10.7150/jca.30300

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lung cancer still remains diagnosed at a late stage although we have novel diagnostic techniques at our disposal. However; for metastatic disease we have novel therapies based on pharmacogenomics. Tumor heterogenity provides us different treatments. There are several reasons for carcinogenesis; fibrosis and scar tissue provides an environment that induces malignancy. In the current review we will try and elucidate the pathways involved from scar tissue to carcinogenesis.

引用

页码：810 / 818

页数：9

共 50 条

[41] 'scar tissue'
MacPherson, A
STAND, 2003, 5 (02): : 42 - 42
[42] SCAR TISSUE
AIGLA, JH
NATION, 1992, 254 (18) : 614 - 614
[43] SCAR TISSUE
WIESELTIER, L
NEW REPUBLIC, 1989, 200 (23) : 18 - &
[44] 'Scar tissue'
Figueredo, D. H.
REVIEW-LITERATURE AND ARTS OF THE AMERICAS, 2007, (74) : 203 - 205
[45] 'Scar tissue'
Taylor, Ihsan
NEW YORK TIMES BOOK REVIEW, 2007, : 28 - 28
[46] A Personalized Treatment for Lung Cancer: Molecular Pathways, Targeted Therapies, and Genomic Characterization
Hensing, Thomas
Chawla, Apoorva
Batra, Rishi
Salgia, Ravi
SYSTEMS ANALYSIS OF HUMAN MULTIGENE DISORDERS, 2014, 799 : 85 - 117
[47] Treatment pathways, resource use and costs in the management of small cell lung cancer
Oliver, E
Killen, J
Kiebert, G
Hutton, J
Hall, R
Higgins, B
Bourke, S
Paschen, B
THORAX, 2001, 56 (10) : 785 - 790
[48] SOFT TISSUE EXPANSION IN THE TREATMENT OF SCAR ALOPECIA IN PRESCHOOL CHILDREN
中华医学杂志(英文版), 1991, (02) : 164 - 167
[49] RESULTS OF TREATMENT OF SCAR-TISSUE CARCINOMA AND FISTULA CARCINOMA
FASCHINGBAUER, M
JURGENS, C
SCHMIDT, HGK
WOLTER, D
CHIRURG, 1995, 66 (11): : 1141 - 1145
[50] SOFT TISSUE EXPANSION IN THE TREATMENT OF SCAR ALOPECIA IN PRESCHOOL CHILDREN
王善昌
陈方龙
李金玉
CHINESEMEDICALJOURNAL, 1991, (02)

← 1 2 3 4 5 →